OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Immunotherapies against HER2-Positive Breast Cancer
Santiago Duro‐Sánchez, Macarena Román Alonso, Joaquı́n Arribas
Cancers (2023) Vol. 15, Iss. 4, pp. 1069-1069
Open Access | Times Cited: 10
Santiago Duro‐Sánchez, Macarena Román Alonso, Joaquı́n Arribas
Cancers (2023) Vol. 15, Iss. 4, pp. 1069-1069
Open Access | Times Cited: 10
Showing 10 citing articles:
CAR-based immunotherapy for breast cancer: peculiarities, ongoing investigations, and future strategies
Zhipu Niu, Jingyuan Wu, Qiancheng Zhao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Zhipu Niu, Jingyuan Wu, Qiancheng Zhao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Current status and innovative developments of CAR-T-cell therapy for the treatment of breast cancer
Hany E. Marei, Khaled Bedair, Anwarul Hasan, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Hany E. Marei, Khaled Bedair, Anwarul Hasan, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Depicting Biomarkers for HER2-Inhibitor Resistance: Implication for Therapy in HER2-Positive Breast Cancer
Alvan Cai, Yuan Chen, Lily S. Wang, et al.
Cancers (2024) Vol. 16, Iss. 15, pp. 2635-2635
Open Access | Times Cited: 1
Alvan Cai, Yuan Chen, Lily S. Wang, et al.
Cancers (2024) Vol. 16, Iss. 15, pp. 2635-2635
Open Access | Times Cited: 1
Inhibiting HER3 Hyperphosphorylation in HER2‐Overexpressing Breast Cancer through Multimodal Therapy with Branched Gold Nanoshells
Eva Villar‐Álvarez, Irene Golán‐Cancela, Alberto Pardo, et al.
Small (2023) Vol. 19, Iss. 50
Open Access | Times Cited: 4
Eva Villar‐Álvarez, Irene Golán‐Cancela, Alberto Pardo, et al.
Small (2023) Vol. 19, Iss. 50
Open Access | Times Cited: 4
Role of single-cell ferroptosis regulation in intercellular communication and skin cutaneous melanoma progression and immunotherapy
Binyu Song, Yixuan Peng, Zheng Yu, et al.
Cancer Immunology Immunotherapy (2023) Vol. 72, Iss. 11, pp. 3523-3541
Open Access | Times Cited: 4
Binyu Song, Yixuan Peng, Zheng Yu, et al.
Cancer Immunology Immunotherapy (2023) Vol. 72, Iss. 11, pp. 3523-3541
Open Access | Times Cited: 4
GENERAL SURGERY CANCER PATİENTS' 2018-2019-2020 HEALTH BOARD DATA
Günay ULUÇ
Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi (2024) Vol. 37, Iss. 3, pp. 259-271
Open Access
Günay ULUÇ
Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi (2024) Vol. 37, Iss. 3, pp. 259-271
Open Access
Antibody Recognition of Human Epidermal Growth Factor Receptor-2 (HER2) Juxtamembrane Domain Enhances Anti-Tumor Response of Chimeric Antigen Receptor (CAR)-T Cells
Guangyu Zhou, Shengyu Fu, Yunsen Zhang, et al.
Antibodies (2024) Vol. 13, Iss. 2, pp. 45-45
Open Access
Guangyu Zhou, Shengyu Fu, Yunsen Zhang, et al.
Antibodies (2024) Vol. 13, Iss. 2, pp. 45-45
Open Access
StAR-related lipid transfer domain protein 3 (STARD3) regulates HER2 and promotes HER2-positive breast cancer progression through interaction with HSP90 and SRC signaling.
Doan Huu Nhat Binh, Tzu‐Chun Cheng, Shih‐Hsin Tu, et al.
PubMed (2023) Vol. 13, Iss. 11, pp. 5151-5173
Closed Access | Times Cited: 1
Doan Huu Nhat Binh, Tzu‐Chun Cheng, Shih‐Hsin Tu, et al.
PubMed (2023) Vol. 13, Iss. 11, pp. 5151-5173
Closed Access | Times Cited: 1
Single domain antibodies specific for HER2 dimerization domain effectively disrupts HER2 dimerization
Ahmad Najafi, Reza Valadan, Hossein Asgarian‐Omran, et al.
International Immunopharmacology (2023) Vol. 124, pp. 110999-110999
Closed Access
Ahmad Najafi, Reza Valadan, Hossein Asgarian‐Omran, et al.
International Immunopharmacology (2023) Vol. 124, pp. 110999-110999
Closed Access
Adoption and use of immunotherapy in breast cancer management in Africa; barriers and prospect- a narrative review
Jimoh Mutiu Alani, Damilola Quazeem Olaoye, A A Abdus-Salam
Annals of Medicine and Surgery (2023) Vol. 85, Iss. 12, pp. 6041-6047
Open Access
Jimoh Mutiu Alani, Damilola Quazeem Olaoye, A A Abdus-Salam
Annals of Medicine and Surgery (2023) Vol. 85, Iss. 12, pp. 6041-6047
Open Access
